Error: Could not add to watchlist. X

3745350 Canada Inc

+ Watchlist
YMI:US
Acquired
YMI:US was acquired by GILD:US
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (CAD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
3745350 Canada Inc. is developing cancer drugs based on technologies licensed primarily from international academic centers. The Company is currently developing a small molecule chemopotentiator for metastatic breast cancer, an EGFr humanized monoclonal antibody, and a GnRH cancer vaccine. 3745350 Canada is also supporting the preclinical development of additional cancer products.
ADDRESS
5045 Orbitor Drive
Building 11 Suite 400
Mississauga, ON L4W 4Y4
Canada
PHONE
1-905-629-9761
  • Leonard Vernon "Len"
    VP:Finance & Administration
  • Ernest Wong
    VP:Business Development
  • Gregg Smith
    VP:Drug Development
Show More